SCHEMBL6095946

SCHEMBL6095946

Cc1cccc(S(=O)(=O)C2CCC2)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 2/20 0.47
KMT2A Q03164 3/20 0.46
HTR2A P28223 1/20 0.46
HTR2C P28335 1/20 0.46
KDM2B Q8NHM5 1/20 0.42
MEN1 O00255 2/20 0.41
ATM Q13315 1/20 0.41
EPHX2 P34913 1/20 0.41
MMP2 P08253 1/20 0.41
FFAR4 Q5NUL3 1/20 0.41
ALDH1A1 P00352 3/20 0.41
MAPT P10636 2/20 0.41
LMNA P02545 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
XBP1 P17861 1/20 0.40
HTT P42858 1/20 0.40
HTR1A P08908 1/20 0.40
HTR1D P28221 1/20 0.40
HTR1B P28222 1/20 0.40
HTR7 P34969 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17410625 0.93 KMT2A (0.49) DRD2KMT2AHTR2AHTR2CMEN1
SCHEMBL21623806 0.85 HTR6 (0.52) DRD2KMT2AHTR2AHTR2CMMP2
SCHEMBL23799261 0.79 SPR (0.46) DRD2KMT2AHTR2AHTR2CMEN1
SCHEMBL19510910 0.79 MBTD1 (0.49) DRD2HTR2AATMMMP2FFAR4
SCHEMBL25483288 0.79 MEN1 (0.51) DRD2KMT2AHTR2AHTR2CMEN1
SCHEMBL19707128 0.79 DRD2 (0.44) DRD2MMP2FFAR4ALDH1A1LMNA
SCHEMBL25680598 0.78 DRD2 (0.44) DRD2HTR2AFFAR4ALDH1A1MAPT
SCHEMBL879307 0.77 ACHE (0.53) KMT2AALDH1A1SMN1; SMN2HTTGAA
SCHEMBL7541817 0.77 HTR2A (0.56) DRD2KMT2AHTR2AHTR2CMEN1
SCHEMBL28021500 0.76 ALDH1A1 (0.45) DRD2KMT2AHTR2AHTR2CKDM2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023109944-A1 TLR MODULATOR AND USE THEREOF 映恩生物制药(苏州)有限公司 2023-06-22 WO disclosed
US-7101892-B2 Sulfone derivatives as 5-HT7 receptor ligands MERCK SHARP & DOHME LTD. 2006-09-05 US disclosed
US-20040229864-A1 Sulfone derivatives as 5-HT7 receptor ligands MERCK SHARP & DOHME LTD. (GB) 2004-11-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040229864-A1 Sulfone derivatives as 5-HT7 receptor ligands HTR7, HTR2C, HTR1A DRD2 74/4885KMT2A 2168/4885HTR2A 12/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.